Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
reported full-year worldwide revenue of about $65 billion in 2025, with Keytruda (pembrolizumab)/Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) sales amounting to roughly $31.7 billion and continuing to be the companys dominant growth engine, alongside contributions from pulmonary arterial hypertension (PAH) drug Winrevair (sotatercept-csrk), pneumonia vaccine Capvaxive (neumococcal 21-valent conjugate vaccine) and animal health products
This method provides precise control over the dosage and allows for flexibility in adjusting the amount based on individual needs
Once prescribed, we'll manage insurance validation and prior authorization, delivering your medication to your preferred location
Lancet Respiratory Med
US$ 25.65
US$ 26.91
US$ 25.43
